Takeda Pharmaceutical is nearing an agreement to buy rival drugmaker Shire, people familiar with the matter said, according to a report in Bloomberg. The deal, if approved, would mark the biggest ever takeover by the Japanese company.
A deal agreement could be announced as early as Tuesday, the deadline set by U.K. regulators for Takeda to make a firm offer for Shire, according to the people, who asked not to be identified because the information is private.
Recent negotiations have centered on the structure of the potential transaction, with Shire seeking an increase in the cash component of Takeda’s 46 billion-pound ($64 billion) bid, the people said. It wasn’t immediately clear if Takeda had consented to the request.